Check out the latest trailer for Korea. IL-2 Series, the newest entry in the acclaimed aerial combat-sim series! Using the backdrop of the Korean War, Korea. IL-2 Series will allow players to take to ...

Nicknamed “The Flying Tank,” the Il-2 Sturmovik was the Soviet Union’s most feared ground-attack aircraft in WWII. First deployed in 1941, its armored design allowed it to survive fierce enemy fire.

When she first played World of Warcraft at 10 years old, Ophélie knew her future would be in the video game industry. With a passion for writing and playing video games, she naturally became a gaming ...

Epic Kamikaze Crash Compilation - IL2 Sturmovik Great Battles Combat Flight Simulator V2 Trump to demolish entire East Wing of White House for ballroom: 'Plans changed' Semi truck driver arrested in ...

Jaime Tugayev is the News Editor for DualShockers with over a decade of experience, and a much longer love for fantasy, shooters and strategy games. Defense and Liberation covers the battles for ...

There are conflicts that have been seen so many times in gaming that they almost become background noise. World War 2 in particular almost has become a default setting, something that may be robbing ...

From the creators of the IL-2 series, Korea. IL-2 Series is the latest entry in the historical flight combat simulator franchise covering a unique era in aviation-based combat that time almost forgot.

IL-2 medicines have shown the ability to kill tumors. Unfortunately, they aren’t very specific and have come to be associated with toxicities. Synthekine is hoping to avoid activating lymphocytes such ...

Launched about eight years ago as a continuation of the iconic IL-2 Sturmovik series, IL-Sturmovik: Battle of Stalingrad received more than two dozen pieces of new content that added a plethora of ...

A pleiotropic cytokine central to the regulation of T-cell responses, interleukin 2 (IL-2), plays an essential role in a huge range of other immune modulatory actions. Image Credit: Sino Biological ...

Sanofi has struck a deal to buy Synthorx for $2.5 billion (€2.3 billion). The takeover, the first of Paul Hudson’s time as CEO, will give Sanofi control of an IL-2 drug it thinks can become a ...